158 related articles for article (PubMed ID: 11836198)
1. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women.
de Kleijn MJ; van der Schouw YT; Verbeek AL; Peeters PH; Banga JD; van der Graaf Y
Am J Epidemiol; 2002 Feb; 155(4):339-45. PubMed ID: 11836198
[TBL] [Abstract][Full Text] [Related]
2. No added value of age at menopause and the lifetime cumulative number of menstrual cycles for cardiovascular risk prediction in postmenopausal women.
Atsma F; van der Schouw YT; Grobbee DE; Hoes AW; Bartelink ML
Int J Cardiol; 2008 Nov; 130(2):190-5. PubMed ID: 18063146
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
[TBL] [Abstract][Full Text] [Related]
4. Reproductive period and risk of dementia in postmenopausal women.
Geerlings MI; Ruitenberg A; Witteman JC; van Swieten JC; Hofman A; van Duijn CM; Breteler MM; Launer LJ
JAMA; 2001 Mar; 285(11):1475-81. PubMed ID: 11255424
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community.
Criqui MH; Suarez L; Barrett-Connor E; McPhillips J; Wingard DL; Garland C
Am J Epidemiol; 1988 Sep; 128(3):606-14. PubMed ID: 3414664
[TBL] [Abstract][Full Text] [Related]
6. Ages at menarche and menopause, and mortality among postmenopausal women.
Zhang X; Liu L; Song F; Song Y; Dai H
Maturitas; 2019 Dec; 130():50-56. PubMed ID: 31706436
[TBL] [Abstract][Full Text] [Related]
7. Age at menopause as a risk factor for cardiovascular mortality.
van der Schouw YT; van der Graaf Y; Steyerberg EW; Eijkemans JC; Banga JD
Lancet; 1996 Mar; 347(9003):714-8. PubMed ID: 8602000
[TBL] [Abstract][Full Text] [Related]
8. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
[TBL] [Abstract][Full Text] [Related]
10. Lifetime estrogen exposure versus age at menopause as mortality predictor.
Jansen SC; Temme EH; Schouten EG
Maturitas; 2002 Oct; 43(2):105-12. PubMed ID: 12385858
[TBL] [Abstract][Full Text] [Related]
11. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
13. Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: the Rotterdam Study.
Jaspers L; Kavousi M; Erler NS; Hofman A; Laven JS; Franco OH
Fertil Steril; 2017 Feb; 107(2):448-456.e1. PubMed ID: 27919437
[TBL] [Abstract][Full Text] [Related]
14. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
15. Association between duration of endogenous estrogen exposure and cardiovascular outcomes: A population - based cohort study.
Farahmand M; Ramezani Tehrani F; Khalili D; Cheraghi L; Bahri Khomami M; Azizi F
Life Sci; 2019 Mar; 221():335-340. PubMed ID: 30763578
[TBL] [Abstract][Full Text] [Related]
16. Reproductive risk factors for cardiovascular disease mortality among postmenopausal women in Korea: the Kangwha Cohort Study, 1985-2005.
Chang HS; Odongua N; Ohrr H; Sull JW; Nam CM
Menopause; 2011 Nov; 18(11):1205-12. PubMed ID: 21659906
[TBL] [Abstract][Full Text] [Related]
17. Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality.
Denes P; Larson JC; Lloyd-Jones DM; Prineas RJ; Greenland P
JAMA; 2007 Mar; 297(9):978-85. PubMed ID: 17341712
[TBL] [Abstract][Full Text] [Related]
18. Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.
Marsh WK; Bromberger JT; Crawford SL; Leung K; Kravitz HM; Randolph JF; Joffe H; Soares CN
Menopause; 2017 Dec; 24(12):1351-1359. PubMed ID: 28719421
[TBL] [Abstract][Full Text] [Related]
19. Lifetime endogenous estrogen exposure and electrocardiographic frontal T axis changes in postmenopausal women.
Atsma F; van der Schouw YT; Grobbee DE; Kors JA; Bartelink ML
Maturitas; 2009 Aug; 63(4):347-51. PubMed ID: 19570627
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.
Atsma F; Bartelink ML; Grobbee DE; van der Schouw YT
Menopause; 2006; 13(2):265-79. PubMed ID: 16645540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
